Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck’s Oxytrol Could Be OTC Trailblazer For Chronic Conditions

Mar 13 2013

• By Dan Schiff

Related Content

<em>Oxytrol</em> Switch Should Hinge On Symptom ID, Not Diagnosis – Merck Consultant

Nov 19 2012

NDAC Puts Hitch In <em>Oxytrol</em> Switch With Negative Self-Selection Vote

Nov 12 2012

Glaxo NRT Promotional Campaign Targets Smokers Not Ready To Quit

Oct 13 2003

Related Companies

Merck & Co., Inc.

Allergan plc

GSK plc

Additional Topics

United States Advertising, Marketing & Sales Manufacturing Prescription To OTC Switch Advisory Committees Regulation Compliance OTC Drugs Consumer BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window